1Spambalg D, Sharifi N, Elisei R, et al. Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation. J Clin Endocrinol Metab, 1996, 81:3898-3901.
2Chazenbalk GD, NagayamaY, Russo D, et al. Functional analysis of the cytoplasmic domains of the human thyrotropin receptor by site-directed mutagenesis. J Biol Chem, 1990, 265: 20970-20975.
3Russo D, Arturi F, Schlumberger M, et al. Activating mutations of the TSH receptor in differentiated thyroid carcinomas. Oncogene, 1995, 11: 1907-1911.
4Russo D, Tumino S, Arturi F, et al. Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab, 1997, 82: 735-738.
5Kitahori Y, Naitoh H, Konishi N, et al. Genetic alterations in N-bis(2-hydroxypropyl) nitrosamine-induced rat transplantable thyroid carcinoma lines: analysis of the TSH-R.G(alpha)s, ras and p53 genes. Carcinogenesis, 1997, 18: 265-269.
6Esapa C, Foster S, Johnson S, et al. G protein and thyrotropin receptor mutations in thyroid neoplasia. J Clin Endocrinol Metab, 1997,82: 493-496.
